32 BROADWAY, SUITE 401, NEW YORK, NY
Enters into Amendment to Employment Agreement with Wan Lung Eng
Term Sheet for the Proposed Acquisition of the Entire Equity Interest
Announces up to $33 Million Convertible Note Financing
Material disclosure
Announces CEO Transition
Founder and Executive Chairman to Convert $54.6 Million in Loans to Equity
Q1
Notice of Late Filing for Quarterly Report
FY 2024
Notice of Late Filing for Annual Report
Q3
Q2
Prospectus filed pursuant to Rule 424(b)(3)
Registration Statement for Securities of Certain Foreign Private Issuers and Certain Canadian Issuers, Offered on a Continuous Basis
Effectiveness Notice
Amended Registration Statement for Securities of Certain Foreign Private Issuers
Registration Statement for Securities to be Offered to Employees
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Amended Schedule 13G - Ownership Report
Initial Statement of Beneficial Ownership